
Dalton Transactions p. 12500 - 12509 (2011)
Update date:2022-07-29
Topics:
Hill, Michael S.
Kociok-K?hn, Gabriele
MacDougall, Dugald J.
Mahon, Mary F.
Weetman, Catherine
Reactions of the β-diketiminato n-butyl magnesium complex, [HC{(Me)CN(2,6-iPr2C6H3)} 2MgnBu], with a range of substituted pyridines and fused-ring quinolines in the presence of PhSiH3 has been found to result in dearomatisation of the N-heterocyclic compounds. This reaction is proposed to occur through the formation of an unobserved N-heterocycle- coordinated magnesium hydride and subsequent hydride transfer via the C2-position of the heterocycle prior to hydride transfer to the C4-position and formation of thermodynamically-favoured magnesium 1,4-dihydropyridides. This reaction is kinetically suppressed for 2,6-dimethylpyridine while the kinetic product, the 1,2-dihydropyridide derivative, was isolated through reaction with 4-methylpyridine (4-methylpyridine), in which case the formation of the 1,4-dihyropyridide is prevented by the presence of the 4-methyl substituent. X-ray structures of the products of these reactions with 4-methylpyridine, 3,5-dimethylpyridine and iso-quinoline comprise a pseudo-tetrahedral magnesium centre while the regiochemistry of the particular dearomatisation reaction is determined by the substitution pattern of the N-heterocycle under observation. The compounds are all air-sensitive and exposure of the magnesium derivatives of dearomatised pyridine and 4-dimethylaminopyridine (DMAP) to air resulted in ligand rearomatisation and the formation of dimeric μ2- η2-η2-peroxomagnesium compounds which have also been subject to analysis by single crystal X-ray diffraction analysis. An unsuccessful extension of this chemistry to N-heterocycle hydrosilylation is suggested to be a consequence of the low basicity of the silane reagent in comparison to the pyridine substrates which effectively impedes any further interaction with the magnesium centres. The Royal Society of Chemistry.
View MoreSuzhou Time-chem Technologies Co., Ltd.
Contact:0512-63983931/68086856
Address:No. 1326 of Binhe Road, New District, Suzhou, Jiangsu, P. R. China
Contact:+86-717-6370352
Address:168 Chengdong Avenue, Yichang, Hubei 443003, P. R.China
Taizhou Elitechemie MediPharma Technology Co.,Ltd.
Contact:+86-523-86810021
Address:Building G14,NO.1 Avenue,China Medical City, Taizhou, Jiangsu,China
Chemvon Biotechnology Co. Ltd.
website:http://www.chemvon.com
Contact:86-21-58550039;86-21-31268550-8004
Address:Suite B-10#, 6999 Chuansha Road, Pudong District, Shanghai 201202, China
Zhejiang Chemline International Co., Ltd.
Contact:+86-571-88062298
Address:Hengdian Industry Area, Dongyang, Zhejiang, China
Doi:10.1039/c5gc01930c
(2016)Doi:10.1021/acs.inorgchem.9b02608
(2019)Doi:10.1002/anie.201104870
(2011)Doi:10.1039/c1dt11279a
(2012)Doi:10.1007/s11164-011-0426-4
(2012)Doi:10.1021/ol203289v
(2012)